Lingling Xu

Tumor Heterogeneity and Drug Resistance Mutations Using ctDNA in Metastatic EGFR Mutation-Positive Lung Adenocarcinoma: A Case Report

Yang Zhang, Jinghua Sun, G. Sun, 2022, OncoTargets and Therapy.

Tumor Heterogeneity and Drug Resistance Mutations Using ctDNA in Metastatic EGFR Mutation-Positive Lung Adenocarcinoma: A Case Report

Yang Zhang, Jinghua Sun, G. Sun, 2022, OncoTargets and Therapy.

LINC00022 acts as an oncogene in colorectal cancer progression via sponging miR-375-3p to regulate FOXF1 expression

Hong-Mei He, Yu-Hong Shang, Lingling Xu, 2022, BMC cancer.

Modified-FOLFIRINOX combined with deep regional hyperthermia in pancreatic cancer: a retrospective study in Chinese patients

B. Wang, Jinghua Sun, Yang Zhang, 2019, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

LINC00022 acts as an oncogene in colorectal cancer progression via sponging miR-375-3p to regulate FOXF1 expression

Jinghua Sun, Hong-Mei He, Yu-Hong Shang, 2022, BMC Cancer.

Prediction of liver cancer prognosis based on immune cell marker genes

Jianfei Liu, J. Qu, Lingling Xu, 2023, Frontiers in Immunology.

miR-451a targeting IL-6R activates JAK2/STAT3 pathway, thus regulates proliferation and apoptosis of multiple myeloma cells

Libo Jiang, Lingling Xu, Ting Lu, 2022, Journal of musculoskeletal & neuronal interactions.

M‐Phase Phosphoprotein 9 upregulation associates with poor prognosis and activates mTOR signaling in gastric cancer

X. Qu, Hong-Mei He, Yu-Hong Shang, 2020, The Kaohsiung journal of medical sciences.

A refractory liver metastatic solid pseudopapillary neoplasm pancreas harbored CTNNB1 mutation showed good response to celecoxib: A case report

J. Sun, Yunkun Zhang, Evenki Pan, 2022, Frontiers in Oncology.